Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lifecare ASA Proxy Solicitation & Information Statement 2026

Apr 1, 2026

3654_rns_2026-04-01_ba819973-f5be-4772-ac71-1f30e5095a6a.html

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

Annual General Meeting

Annual General Meeting

Lifecare ASA will hold the annnual General Meeting on 23 April 2026 at 10:00

(CEST).

For complete information about registration, participation, agenda and voting,

please see the enclosed notice.

Full agenda and documents are available on

https://lifecare.no/investor/governance/

About us

Lifecare ASA is a medical sensor company developing technology for sensing and

monitoring of various body analytes. Lifecare's focus is to bring the next

generation of Continuous Glucose Monitoring systems to market. Lifecare

enables osmotic pressure as sensing principle. Lifecare's sensor technology is

suitable for identifying and monitoring the occurrence of a wide range of

analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

This information is subject to disclosure under the Norwegian Securities

Trading Act, §5-12. The information was submitted for publication, through the

agency of the contact persons set out above, at 2026-04-01 22:00 CEST.